Illumina genotyping drug
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| ATAC-seq | interacts_with | Illumina genotyping | — | 1 |
| ATAC-seq | associated_with | Illumina genotyping | — | 1 |
| Illumina genotyping | interacts_with | dbSNP | — | 1 |
| Illumina genotyping | biomarker_for | substance use | — | 1 |
| Illumina genotyping | associated_with | trans-eQTL | — | 1 |
| SNP | associated_with | Illumina genotyping | — | 1 |
Mentioned in (5)
Papers in which this entity is mentioned.
- CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder. (2019)
- Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. (2011)
- Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. (2011)
- Allele-specific copy number analysis of tumors. (2010)
- Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. (2008)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| illumina genotyping | drug | 3 | 4 |
| illumina snps | variant | 2 | 2 |
| autosomal illumina snps | drug | — | — |